These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 38376511)
1. Withdrawal syndrome after antipsychotics discontinuation: an analysis of the WHO database of spontaneous reports (Vigibase) between 2000 and 2022. Storck W; de Laportalière TT; Yrondi A; Javelot H; Berna F; Montastruc F Psychopharmacology (Berl); 2024 Jun; 241(6):1205-1212. PubMed ID: 38376511 [TBL] [Abstract][Full Text] [Related]
2. Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database. de Filippis R; Kane JM; Arzenton E; Moretti U; Raschi E; Trifirò G; Barbui C; De Fazio P; Gastaldon C; Schoretsanitis G Drug Saf; 2024 Aug; 47(8):745-757. PubMed ID: 38722481 [TBL] [Abstract][Full Text] [Related]
3. Drug-induced parkinsonism: Revisiting the epidemiology using the WHO pharmacovigilance database. de Germay S; Montastruc F; Carvajal A; Lapeyre-Mestre M; Montastruc JL Parkinsonism Relat Disord; 2020 Jan; 70():55-59. PubMed ID: 31865063 [TBL] [Abstract][Full Text] [Related]
4. An original pharmacoepidemiological-pharmacodynamic method: application to antipsychotic-induced movement disorders. Nguyen TT; Pariente A; Montastruc JL; Lapeyre-Mestre M; Rousseau V; Rascol O; Bégaud B; Montastruc F Br J Clin Pharmacol; 2017 Mar; 83(3):612-622. PubMed ID: 27687785 [TBL] [Abstract][Full Text] [Related]
5. Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics: A Disproportionality Analysis Using VigiBase. Man WH; Wilting I; Souverein P; Meyboom R; Egberts T; Heerdink ER J Clin Psychopharmacol; 2020; 40(3):283-286. PubMed ID: 32332463 [TBL] [Abstract][Full Text] [Related]
6. Antipsychotics and risk of QT prolongation: a pharmacovigilance study. Bordet C; Garcia P; Salvo F; Touafchia A; Galinier M; Sommet A; Montastruc F Psychopharmacology (Berl); 2023 Jan; 240(1):199-202. PubMed ID: 36515735 [TBL] [Abstract][Full Text] [Related]
7. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias. Pariente A; Gregoire F; Fourrier-Reglat A; Haramburu F; Moore N Drug Saf; 2007; 30(10):891-8. PubMed ID: 17867726 [TBL] [Abstract][Full Text] [Related]
8. A pharmacovigilance study of the association between antipsychotic drugs and venous thromboembolism based on Food and Drug Administration Adverse Event Reporting System data. Yan Y; Wang L; Yuan Y; Xu J; Chen Y; Wu B Expert Opin Drug Saf; 2024 Jun; 23(6):771-776. PubMed ID: 37615268 [TBL] [Abstract][Full Text] [Related]
9. Antipsychotics and obsessive-compulsive disorder/obsessive-compulsive symptoms: A pharmacovigilance study of the FDA adverse event reporting system. Burk BG; DiGiacomo T; Polancich S; Pruett BS; Sivaraman S; Birur B Acta Psychiatr Scand; 2023 Jul; 148(1):32-46. PubMed ID: 37194481 [TBL] [Abstract][Full Text] [Related]
10. Withdrawal Syndrome Following Discontinuation of 28 Antidepressants: Pharmacovigilance Analysis of 31,688 Reports from the WHO Spontaneous Reporting Database. Gastaldon C; Schoretsanitis G; Arzenton E; Raschi E; Papola D; Ostuzzi G; Moretti U; Seifritz E; Kane JM; Trifirò G; Barbui C Drug Saf; 2022 Dec; 45(12):1539-1549. PubMed ID: 36400895 [TBL] [Abstract][Full Text] [Related]
11. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555 [TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotics: mechanism of action. Seeman P Can J Psychiatry; 2002 Feb; 47(1):27-38. PubMed ID: 11873706 [TBL] [Abstract][Full Text] [Related]
13. Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case. Meyer-Massetti C; Vaerini S; Rätz Bravo AE; Meier CR; Guglielmo BJ Int J Clin Pharm; 2011 Oct; 33(5):806-14. PubMed ID: 21809143 [TBL] [Abstract][Full Text] [Related]
14. Exploring a Safety Signal of Antipsychotic-Associated Pneumonia: A Pharmacovigilance-Pharmacodynamic Study. Cepaityte D; Siafis S; Egberts T; Leucht S; Kouvelas D; Papazisis G Schizophr Bull; 2021 Apr; 47(3):672-681. PubMed ID: 33289848 [TBL] [Abstract][Full Text] [Related]
15. Hyponatraemia as an adverse drug reaction of antipsychotic drugs: a case-control study in VigiBase. Mannesse CK; van Puijenbroek EP; Jansen PA; van Marum RJ; Souverein PC; Egberts TC Drug Saf; 2010 Jul; 33(7):569-78. PubMed ID: 20553058 [TBL] [Abstract][Full Text] [Related]
16. Weight Gain During Antipsychotic Treatment in Children, Adolescents, and Adults: A Disproportionality Analysis in the Global Pharmacovigilance Database, Vigibase Kaguelidou F; Valtuille Z; Durrieu G; Delorme R; Peyre H; Treluyer JM; Montastruc F; Chouchana L Drug Saf; 2023 Jan; 46(1):77-85. PubMed ID: 36459374 [TBL] [Abstract][Full Text] [Related]